Difference between revisions of "Papillary thyroid carcinoma"

Jump to navigation Jump to search
BRAF
(BRAF)
 
Line 10: Line 10:
| IHC        = HBME-1 +ve, [[CK19]] +ve, Galectin-3 +ve, thyroglobulin +ve, TTF-1 +ve
| IHC        = HBME-1 +ve, [[CK19]] +ve, Galectin-3 +ve, thyroglobulin +ve, TTF-1 +ve
| EM        =
| EM        =
| Molecular  =
| Molecular  = BRAF mutation - commonly
| IF        =
| IF        =
| Gross      =
| Gross      =
Line 272: Line 272:


===Molecular===
===Molecular===
*Currently not widely used in a diagnostic context.
*BRAF mutation.<ref name=pmid35670964>{{cite journal |authors=Lam AK |title=Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification |journal=Methods Mol Biol |volume=2534 |issue= |pages=1–15 |date=2022 |pmid=35670964 |doi=10.1007/978-1-0716-2505-7_1 |url=}}</ref>


====Tabular summary====
====Tabular summary====
48,475

edits

Navigation menu